Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/201877
Title: RINT1 deficiency disrupts lipid metabolism and underlies a complex hereditary spastic paraplegia
Author: Launay, Nathalie
Ruiz, Montserrat
Planas Serra, Laura
Verdura, Edgard
Rodríguez Palmero, Agustí
Schlüter, Agatha
Goicoechea, Leire
Guilera, Cristina
Casas, Josefina
Campelo, Felix
Jouanguy, Emmanuelle
Casanova, Jean Laurent
Boespflug Tanguy, Odile
Vazquez Cancela, Maria
González Gutiérrez-Solana, Luis
Casasnovas, Carlos
Area Gomez, Estela
Pujol, Aurora
Keywords: Paraplegia
Metabolisme dels lípids
Neurosciences
Paraplegia
Lipid metabolism
Neurociències
Issue Date: 17-Jul-2023
Publisher: American Society for Clinical Investigation
Abstract: The Rad50 interacting protein 1 (Rint1) is a key player in vesicular trafficking between the ER and Golgi apparatus. Biallelic variants in RINT1 cause infantile-onset episodic acute liver failure (ALF). Here, we describe 3 individuals from 2 unrelated families with novel biallelic RINT1loss-of-function variants who presented with early onset spastic paraplegia, ataxia, optic nerve hypoplasia, and dysmorphic features, broadening the previously described phenotype. Our functional and lipidomic analyses provided evidence that pathogenic RINT1 variants induce defective lipid-droplet biogenesis and profound lipid abnormalities in fibroblasts and plasma that impact both neutral lipid and phospholipid metabolism, including decreased triglycerides and diglycerides, phosphatidylcholine/phosphatidylserine ratios, and inhibited Lands cycle. Further, RINT1 mutations induced intracellular ROS production and reduced ATP synthesis, affecting mitochondria with membrane depolarization, aberrant cristae ultrastructure, and increased fission. Altogether, our results highlighted the pivotal role of RINT1 in lipid metabolism and mitochondria function, with a profound effect in central nervous system development.
Note: Reproducció del document publicat a: https://doi.org/10.1172/JCI162836
It is part of: Journal of Clinical Investigation, 2023, vol. 133, num. 14, p. e162836
URI: http://hdl.handle.net/2445/201877
Related resource: https://doi.org/10.1172/JCI162836
ISSN: 1558-8238
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
render.pdf16.16 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons